Texas House Bill HB1373

Texas 2023 - 88th Regular

• Filed: 1/17/23

Caption

Relating to a pilot program for the safe disposal of controlled substance prescription drugs.

Impact

If enacted, HB 1373 would amend the Health and Safety Code by adding Chapter 442A, which would formalize the state's commitment to promoting safe disposal practices. The program would require participating pharmacies to meet specific standards regarding collection receptacles and disposal procedures, ensuring that the disposal process is compliant with the federal regulations. This would not only provide safe and anonymous disposal options for members of the public but also aim to reduce the potential environmental hazards associated with improper drug disposal.

Summary

House Bill 1373 proposes the establishment of a pilot program aimed at the safe disposal of controlled substance prescription drugs in the state of Texas. Specifically, the bill directs the Texas State Board of Pharmacy to create a controlled substance prescription drug safe disposal pilot program that would facilitate the collection of unused prescription drugs from the public. The program emphasizes increasing the number of accessible disposal locations and is particularly focused on rural and underserved areas where access to such services may be limited.

Sentiment

Conversations surrounding HB 1373 have exhibited a positive sentiment among stakeholders concerned with public health and safety. Proponents, including pharmacy representatives and public health advocates, have expressed strong support for the bill, highlighting the critical need for safe disposal methods to combat the opioid crisis and prevent accidental poisonings. However, it is important to note that the bill's implementation may face financial challenges, as funding details and the sustainability of participating pharmacies’ involvement were discussed as potential points of contention.

Contention

Notably, there are concerns regarding the allocation of funds and resources to support the program in the long term. While the pilot program is anticipated to have initial funding from the opioid abatement account, questions remain about the program's continuity and effectiveness after its expiration in 2029. The requirement for pharmacies to actively participate and comply with state and federal regulations may also raise concerns regarding the operational burden on smaller or rural pharmacies that may already struggle with resource limitations.